Paper Details

  1. Home
  2. Paper Details

Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: systematic review and meta-analysis.

Author: Bosques-PadillaF J, González-GonzálezJ A, Gutiérrez-UdaveR, Maldonado-GarzaH J, Martínez-VázquezM A, Vázquez-ElizondoG

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Antispasmodics were more effective than placebo in treating irritable bowel syndrome (IBS), with no significant adverse events.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: Irritable bowel syndrome (IBS) is characterized by recurrent abdominal pain, bloating, and changes in bowel habit. AIMS: To determine the clinical effectiveness of the antispasmodic agents available in Mexico for the treatment of IBS. METHODS: We carried out a systematic review and m...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.rgmx.2012.04.002

データ提供：米国国立医学図書館（NLM）

Finding Relief for Irritable Bowel Syndrome: A Systematic Review of Antispasmodics

This research focuses on the common and often debilitating condition of irritable bowel syndrome (IBS), exploring the effectiveness of antispasmodic agents in its treatment. The authors conducted a systematic review and meta-analysis of clinical trials on antispasmodic agents for IBS, providing a comprehensive assessment of their efficacy and safety.

Navigating the Terrain of IBS Treatment

The study found that antispasmodic agents were more effective than placebo in treating IBS, with significant improvements in global symptom improvement, abdominal pain, and bloating. The authors also investigated the potential benefits of combining antispasmodic agents with simethicone, finding that this combination further enhanced the effectiveness of treatment.

Seeking Relief and Improving Quality of Life

This research provides valuable insights for individuals suffering from IBS. The study suggests that antispasmodic agents, alone or in combination with simethicone, can offer significant relief from the symptoms of IBS, ultimately improving quality of life.

Dr. Camel's Conclusion

This research is like a soothing oasis in the harsh desert of IBS symptoms. The study's findings offer hope for a better quality of life for individuals suffering from this condition, reminding us that there are effective treatment options available.

Date :
  1. Date Completed 2013-12-16
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

22672854

DOI: Digital Object Identifier

10.1016/j.rgmx.2012.04.002

Related Literature

Article Analysis
・Effective treatment of irritable bowel syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.